TPWA
IRON icon

Twin Peaks Wealth Advisors’s Disc Medicine IRON Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$64 – 1201
2026
Q1 		$64 Buy
+1
New +$69 ﹤0.01% 2281

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Twin Peaks Wealth Advisors's IRON Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of Disc Medicine (IRON) in Q2 2026, closing a stake of 1 share — an estimated $64 sold.

Twin Peaks Wealth Advisors first reported a position in IRON in Q1 2026 and held it in 1 quarter. The position peaked at $64 in Q1 2026. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Twin Peaks Wealth Advisors reported no remaining Disc Medicine position as of Q2 2026 after selling out during the quarter.
  • Twin Peaks Wealth Advisors sold 1 Disc Medicine share in Q2 2026, an estimated $64.
  • Twin Peaks Wealth Advisors first reported a position in Disc Medicine in Q1 2026 and held it in 1 quarter.
  • Twin Peaks Wealth Advisors's Disc Medicine position peaked at $64 in Q1 2026.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.